Monday, September 7, 2009

Aurobindo receives US FDA and Swissmedic approvals

Aurobindo Pharma has received US FDA final approval for Risperidone oral solution 1mg/ml. The product is generic equivalent to Risperidal oral solution 1mg/ml of Ortho-McNeil Janssen. It is indicated in the treatment of schizophrenia and falls under the neurological segment.

The details can be read here.

No comments: